The abstract is read at the publisher; the summary is JClub's.
In 43,709 predominantly European-ancestry UK Biobank participants, plasma proteomics links 935 proteins to seven sleep traits, highlighting immune-metabolic pathways and neurochemical signaling.
- Why it matters: Sleep disturbance’s plasma protein signatures are not well mapped, limiting mechanistic insight and testable targets for how sleep traits relate to disease risk.
- What they did: The study built an atlas of proteomic signatures for seven self-reported sleep traits and a sleep health score, then used genomic structural equation modeling and bidirectional Mendelian randomization with colocalization (PP.H4 = 0.98) to prioritize proteins.
- The result: One protein, LTA, is robustly supported for a putative causal effect on nighttime sleep adequacy, and 16 additional genetically supported candidates associate prospectively with incident cardiovascular disease, stroke, type 2 diabetes, dementia, chronic kidney disease, depression, and mortality over a median 13.6-year follow-up.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.